IBL-101

N/A

Report date: 2025/01/26 18:28:49
NME

Base Information

Drug NameIBL-101
Drug Alias Namepan-PIM kinase inhibitor (Inflection Biosciences)IBL-101
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerine/threonine-protein kinase pim-2 inhibitorsSerine/threonine-protein kinase pim-3 inhibitorsProto-oncogene serine/threonine-protein kinase Pim-1 inhibitors
TargetsSerine/threonine-protein kinase pim-2Proto-oncogene serine/threonine-protein kinase Pim-1Serine/threonine-protein kinase pim-3
Therapy Area/IndicationsSolid tumoursPsoriasisLupus Nephritis +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIreland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesInflection Biosciences Ltd
China Registration ClassN/A

Develop Information

Active CompaniesNational Children'S Research CentreTrinity College DublinInflection Biosciences Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursPsoriasisLupus Nephritis +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A